Showing results (1871-1880 of 2,125) with videos related to

Sort By:
Pageof 213
World Journal of Gastroenterology|August 5, 2009
Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinomaKe-Cheng Xu, Li-Zhi Niu, Qiang Zhou, et al.
Cell Communication and Signaling : CCS|January 5, 2024
Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axisXiao-Jing Chen, Chu-Hong Guo, Zi-Ci Wang, et al.
Clinical Chemistry and Laboratory Medicine|October 21, 2015
Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndromeTing-Juan Zhang, Jing-Dong Zhou, Dong-Qin Yang, et al.
Medical Oncology (Northwood, London, England)|November 28, 2014
Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemiaJing-Dong Zhou, Lei Yang, Ying-Ying Zhang, et al.
Mediators of Inflammation|July 17, 2018
Predictive Value of Combined LIPS and ANG-2 Level in Critically Ill Patients with ARDS Risk FactorsZhi Xu, Guo-Ming Wu, Qi Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 27, 2017
Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemiaJing-Dong Zhou, Dong-Ming Yao, Li Han, et al.
Oncotarget|February 12, 2015
EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancerLucas J Brand, Margaret E Olson, Preethi Ravindranathan, et al.
Biomaterials Science|February 16, 2024
Correction: MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancerJie Liu, Chang-Qing Yang, Qiang Chen, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 3, 2022
Network Meta-Analysis of Acupoint Catgut Embedding in Treatment of Simple ObesityZhuo-Yuan Wang, Xiao-Yan Li, Xiao-Jun Gou, et al.
Radiation Oncology (London, England)|January 13, 2021
Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapyChengbing Zeng, Tiantian Zhai, Jianzhou Chen, et al.
Pageof 213